A

Cannabidiol Lacks Direct Effect on Cortical Excitability: A Randomized, Double Blind, Placebo Controlled, 3‐Way Crossover Trial

Clinical Pharmacology & Therapeutics, vol. 119, pp. 147–157

Abstract

Cannabidiol (CBD) is approved as an adjunctive treatment of seizures associated with Dravet syndrome, Lennox-Gastaut Syndrome, and tuberous sclerosis. Its therapeutic and adverse effects are thought to arise, at least partly, from a pharmacokinetic interaction with clobazam, another anti-seizure medication (ASM). The goal of this study was to evaluate the intrinsic anti-epileptic and sedative properties of CBD. A randomized, double-blind, placebo-controlled, 3-way crossover trial was conducted in 25 healthy males. On each visit, single doses of 30 mg CBD, 700 mg CBD, or placebo were administered orally. The effects of CBD on cortical excitability were measured using transcranial magnetic stimulation (TMS) combined with electromyography (EMG) and electroencephalography (EEG). Sedative properties were assessed using a validated CNS test battery. Pharmacokinetic sampling was performed. Data were analyzed using a mixed-effects model. CBD did not have significant effects on single pulse and paired pulse TMS-EMG parameters, compared to placebo. Some significant clusters were seen on paired pulse TMS-EEG at 3 hours post-dose for 30 mg CBD, and at 3 and 5 hours post-dose for 700 mg CBD. CBD did not have significant effects on any tests assessing its sedative properties. These results suggest that CBD may lack intrinsic anti-epileptic and sedative properties and that its effects could be primarily a product of interactions with other drugs, notably clobazam.

Authors 8

  1. Leiden University · Leiden University Medical Center · Centre for Human Drug Research

    Affiliation as printed

    Centre for Human Drug Research Leiden The Netherlands

    Leiden University Medical Centre Leiden The Netherlands

    Centre for Human Drug Research, Leiden, The Netherlands

    Leiden University Medical Centre, Leiden, The Netherlands

  2. Leiden University · Leiden University Medical Center · Centre for Human Drug Research

    Affiliation as printed

    Centre for Human Drug Research Leiden The Netherlands

    Leiden University Medical Centre Leiden The Netherlands

    Centre for Human Drug Research, Leiden, The Netherlands

    Leiden University Medical Centre, Leiden, The Netherlands

  3. Centre for Human Drug Research

    Affiliation as printed

    Centre for Human Drug Research Leiden The Netherlands

    Centre for Human Drug Research, Leiden, The Netherlands

  4. Centre for Human Drug Research

    Affiliation as printed

    Centre for Human Drug Research Leiden The Netherlands

    Centre for Human Drug Research, Leiden, The Netherlands

  5. Centre for Human Drug Research

    Affiliation as printed

    Centre for Human Drug Research Leiden The Netherlands

    Centre for Human Drug Research, Leiden, The Netherlands

  6. Centre for Human Drug Research

    Affiliation as printed

    Centre for Human Drug Research Leiden The Netherlands

    Centre for Human Drug Research, Leiden, The Netherlands

  7. Centre for Human Drug Research

    Affiliation as printed

    Centre for Human Drug Research Leiden The Netherlands

    Centre for Human Drug Research, Leiden, The Netherlands

  8. Leiden University · Leiden University Medical Center · Centre for Human Drug Research

    Affiliation as printed

    Centre for Human Drug Research Leiden The Netherlands

    Leiden University Medical Centre Leiden The Netherlands

    Centre for Human Drug Research, Leiden, The Netherlands

    Leiden University Medical Centre, Leiden, The Netherlands

Cited by 2 stored of 2

2 results

No patents citing this paper on Lens.org (checked 2026-10-11).

References 54